Diseases, Conditions, Syndromes

Shared antibodies may push COVID variants: study

Researchers at Vanderbilt University Medical Center have found that people recovering from COVID-19 and those vaccinated against the causative virus, SARS-CoV-2, produce identical clones, or groups, of antibody-producing ...

Oncology & Cancer

94% of patients with cancer respond well to COVID-19 vaccines

In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients ...

Diseases, Conditions, Syndromes

Combination therapy protects against advanced Marburg virus disease

A new study conducted at the Galveston National Laboratory at the The University of Texas Medical Branch at Galveston (UTMB) has shown substantial benefit to combining monoclonal antibodies and the antiviral remdesivir against ...

page 2 from 11